Variant report

Variant	rs12170307
Chromosome Location	chr22:33156786-33156787
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	22:32920308-32927723..22:33154607-33167707	H1-hESC	embryonic stem cell:	embryo
2	22:32578360-32590642..22:33154607-33167707	K562	blood:
3	22:32342898-32343477..22:33154607-33167707	Hela-S3	cervix:
4	22:32764253-32784733..22:33154607-33167707	K562	blood:
5	chr22:33115192..33117854-chr22:33156131..33157646,2	MCF-7	breast:
6	22:32053085-32061138..22:33154607-33167707	K562	blood:
7	22:33154607-33167707..22:33262063-33266567	Hela-S3	cervix:
8	22:33154607-33167707..22:33339333-33353583	Hela-S3	cervix:
9	22:32292186-32294405..22:33154607-33167707	K562	blood:
10	22:32594665-32606395..22:33154607-33167707	H1-hESC	embryonic stem cell:	embryo

No data

Variant related genes	Relation type
ENSG00000241954	Chromatin interaction
ENSG00000185666	Chromatin interaction
ENSG00000232218	Chromatin interaction
ENSG00000254127	Chromatin interaction
ENSG00000128245	Chromatin interaction
ENSG00000243519	Chromatin interaction
ENSG00000230736	Chromatin interaction
ENSG00000100150	Chromatin interaction
ENSG00000128253	Chromatin interaction
ENSG00000242082	Chromatin interaction
ENSG00000205853	Chromatin interaction
ENSG00000241878	Chromatin interaction

Extended variants
information (count: 20 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:17)

rs_ID	r²[population]
rs1005662	1.00[EUR][1000 genomes]
rs1005663	1.00[EUR][1000 genomes]
rs1005664	1.00[EUR][1000 genomes]
rs11912124	0.89[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs11914041	0.94[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs130534	0.87[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs1365835	1.00[EUR][1000 genomes]
rs16991203	0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs1894457	0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs5998658	1.00[EUR][1000 genomes]
rs9619309	0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs9619310	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs9621551	0.94[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs9621561	0.89[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs9621566	1.00[AMR][1000 genomes]
rs9621599	1.00[EUR][1000 genomes]
rs9621600	1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1064719	chr22:33028891-33159636	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Bivalent/Poised TSS Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	22 gene(s)	inside rSNPs	diseases
2	esv3389882	chr22:33154777-33157325	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	12 gene(s)	inside rSNPs	diseases
3	esv3328989	chr22:33154902-33157275	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	12 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:50 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr22:33149200-33157200	Weak transcription	NHLF	lung
2	chr22:33149400-33157400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr22:33149600-33157000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr22:33151000-33158000	Weak transcription	Right Ventricle	heart
5	chr22:33151000-33175400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr22:33151200-33157000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr22:33151200-33157000	Weak transcription	NH-A	brain
8	chr22:33152800-33158000	Weak transcription	Pancreas	Pancrea
9	chr22:33154000-33156800	Weak transcription	Fetal Thymus	thymus
10	chr22:33154400-33157800	Weak transcription	HUES48 Cell Line	embryonic stem cell
11	chr22:33155000-33161400	Enhancers	Right Atrium	heart
12	chr22:33155400-33156800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr22:33155400-33157000	Weak transcription	NHDF-Ad	bronchial
14	chr22:33156200-33156800	Enhancers	Brain Anterior Caudate	brain
15	chr22:33156200-33156800	Enhancers	Hela-S3	cervix
16	chr22:33156200-33158800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr22:33156200-33158800	Enhancers	Left Ventricle	heart
18	chr22:33156200-33158800	Enhancers	Lung	lung
19	chr22:33156200-33158800	Enhancers	HSMMtube	muscle
20	chr22:33156200-33160600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
21	chr22:33156200-33161400	Enhancers	Adipose Nuclei	Adipose
22	chr22:33156400-33156800	Enhancers	Psoas Muscle	Psoas
23	chr22:33156400-33157200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
24	chr22:33156400-33157200	Enhancers	Brain Substantia Nigra	brain
25	chr22:33156400-33157400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr22:33156400-33157400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr22:33156400-33157400	Enhancers	Fetal Muscle Leg	muscle
28	chr22:33156400-33157600	Enhancers	Placenta	Placenta
29	chr22:33156400-33157600	Enhancers	Sigmoid Colon	Sigmoid Colon
30	chr22:33156400-33157600	Flanking Active TSS	HSMM	muscle
31	chr22:33156400-33157800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr22:33156400-33158400	Enhancers	Muscle Satellite Cultured Cells	--
33	chr22:33156400-33158400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
34	chr22:33156400-33158400	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
35	chr22:33156400-33158800	Enhancers	Primary hematopoietic stem cells short term culture	blood
36	chr22:33156400-33158800	Enhancers	Osteobl	bone
37	chr22:33156400-33159000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
38	chr22:33156400-33160200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr22:33156400-33161600	Enhancers	Spleen	Spleen
40	chr22:33156600-33156800	Enhancers	Rectal Mucosa Donor 31	rectum
41	chr22:33156600-33157000	Enhancers	Fetal Muscle Trunk	muscle
42	chr22:33156600-33157200	Enhancers	Fetal Stomach	stomach
43	chr22:33156600-33157400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr22:33156600-33157800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr22:33156600-33157800	Enhancers	Fetal Lung	lung
46	chr22:33156600-33158400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
47	chr22:33156600-33158400	Enhancers	Primary hematopoietic stem cells	blood
48	chr22:33156600-33158400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
49	chr22:33156600-33158400	Enhancers	HepG2	liver
50	chr22:33156600-33158800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links